Sio Capital Management’s Oasmia Pharmaceutical AB OASM Stock Holding History

Sio Capital Management’s Portfolio OASM Stock Details OASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-203,170	Closed	-$179K	–	61
2017 Q4	$179K	Hold	203,170	–	–	0.1%	45
2017 Q3	$211K	Hold	203,170	–	–	0.11%	51
2017 Q2	$214K	Buy	203,170 +5,700	+3%	+$10K	0.1%	57
2017 Q1	$377K	Buy	197,470 +15,200	+8%	+$35.6K	0.21%	43
2016 Q4	$512K	Buy	182,270 +60,170	+49%	+$178K	0.3%	42
2016 Q3	$365K	Sell	122,100 -900	-0.7%	-$2.99K	0.25%	32
2016 Q2	$424K	Hold	123,000	–	–	0.22%	39
2016 Q1	$523K	Hold	123,000	–	–	0.19%	38
2015 Q4	$445K	Buy	+123,000	New	+$484K	0.2%	39

Other funds holding OASM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sio Capital Management's OASM Position: Q1 2018 in Review

Sio Capital Management sold out of Oasmia Pharmaceutical AB (OASM) in Q1 2018, closing a stake of 203,170 shares — an estimated $179K sold.

Sio Capital Management first reported a position in OASM in Q4 2015 and held it in 9 quarters. The position peaked at $523K in Q1 2016. 4 funds tracked by Wall St. Rank hold OASM as of Q1 2018.

Sio Capital Management reported no remaining Oasmia Pharmaceutical AB position as of Q1 2018 after selling out during the quarter.
Sio Capital Management sold 203,170 Oasmia Pharmaceutical AB shares in Q1 2018, an estimated $179K.
Sio Capital Management first reported a position in Oasmia Pharmaceutical AB in Q4 2015 and held it in 9 quarters.
Sio Capital Management's Oasmia Pharmaceutical AB position peaked at $523K in Q1 2016.
4 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q1 2018.

Based on Sio Capital Management's 13F filing for Q1 2018, filed 15 May 2018.